Abstract: On the basis of the human immunodeficiency virus (HIV) infection dynamics model proposed by Adams, the authors propose an extended model that aims at incorporating the influence of activation-induced apoptosis of CD4 þ and CD8 þ T-cells on the immune system response of HIV-infected patients. Through this model, the authors study the influence of this phenomenon on the time evolution of specific cell populations such as plasma concentrations of HIV copies, or blood concentrations of CD4 þ and CD8 þ T-cells. In particular, this study shows that depending on its intensity, the apoptosis phenomenon can either favour or mitigate the long-term evolution of the HIV infection.
Introduction
The human immunodeficiency virus (HIV) is a retrovirus that may lead to the lethal acquired immune deficiency Syndrome (AIDS). After initial contact and inclusion of the HIV particle into specific types of cell of the immune system, there is a cascade of intracellular events leading to the production of massive numbers of new viral copies, the death of infected cells and ultimately the devastation of the immune system.
Since the first identification of the disease in 1981, intensive studies have been carried out to understand the fundamental HIV infection mechanisms. HIV primarily infects cells of the human immune system such as helper T-cells (specifically CD4
þ T-cells), macrophages and dendritic cells. When the number of CD4 þ T-cells declines below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections. Progression from HIV infection to AIDS is primarily due to an extensive depletion of CD4 þ T-cells. Cell-mediated immunity is an immune response that does not involve antibodies but rather involves the activation of macrophages, natural killer cells, antigen-specific cytotoxic T-lymphocytes and the release of various cytokines in response to an antigen.
Several mechanisms are involved in the loss of CD4 þ T-cells and this topic is one of the most controversial issues in recent AIDS research. T-cell loss may be a consequence of direct destruction by the virus (direct virus-induced cytolysis) or of a defective T-cell generation. In 1991, apoptosis, also called programmed cell death, has been suggested as another mechanism responsible for T-cell depletion during the evolution of HIV-1 infection and an extensive body of recent literature is supporting this
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hypothesis [1] [2] [3] [4] [5] . In HIV-infected patients, both infected and uninfected cells undergo accelerated apoptosis but, remarkably, the vast majority of the cells that undergo apoptosis are uninfected [6] . Furthermore, the level of apoptosis in HIV-1 infected patients is correlated to the levels of circulating CD4 þ T-cells and the stage of disease [6] , which reinforces the idea that apoptosis induced by the HIV infection plays an important role in the death of the lymphocytes.
Mathematical analysis of the HIV/AIDS infection has been actively studied since the middle of the 1990's. Several authors have proposed mathematical models to describe the HIV infection dynamics [7] [8] [9] [10] [11] [12] . These models are often represented by a set of nonlinear ordinary differential equations (ODEs) which model the long-term interaction between the immune system and the virus. They generally take into consideration several biological phenomena that influence the infection process, but, to the best of our knowledge, no mathematical model has yet tried to explain the influence of the activation-induced apoptosis phenomenon on the HIV infection dynamics.
In this paper, we propose a modification of the model proposed by Adams et al. in [7] . This modification aims at modelling the activation-induced apoptosis phenomenon and at analysing its influence on the HIV infection dynamics. Similar to the model initially proposed by Adams et al., our model is characterised by different equilibrium points and does not directly aim at predicting the long-term collapse of the immune system, which may be due to several factors such as virus mutations or fatigue of the immune system resulting in progressive thymus degradation.
where
2 ) the number of non-infected (infected) macrophages (in cells/ml), V the number of free HIVs (in virions/ml) and E the number of HIV-specific cytotoxic CD8
þ T-cells (in cells/ml). The model proposed in [7] also includes two control inputs representing the effect of the two main types of drugs (protease inhibitors and reverse transcriptase inhibitors) typically used in highly active anti-retroviral therapy. In this paper, we specifically focus on the mathematical modelisation of activation-induced apoptosis for non-treated patients and therefore do not consider these two control inputs.
The values of the different parameters of the model are taken from [7] :
As a general remark, some side simulations have shown that all the results presented in this paper are qualitatively robust with respect to perturbations of the nominal parameter values listed above. We therefore only consider these nominal values in the presented results.
In order to provide insight into the properties of this model, we briefly discuss its main characteristics.
As shown in [7] , the system of ODEs (1)-(6) exhibits four physical equilibrium points (and several non-physical ones, omitted here, for which one or several state variables are negative). The first three physical equilibrium points have a clear biological interpretation. The fourth equilibrium point has no clear biological interpretation and can be shown to be locally unstable. Nevertheless, this latter equilibrium point plays an important role in the apoptosis-compliant dynamics as we will discuss later in Section 3.
These physical equilibrium points are, respectively, 1. an uninfected unstable equilibrium point
2. an infected, so-called 'healthy', locally stable equilibrium point 5, 11945, 46, 63919, 24) for which T-cells are depleted and the viral load is very high;
4. an infected locally unstable equilibrium point Apoptosis, also called programmed cell death, is a process of deliberate life relinquishment by a cell in a multicellular organism. It is an important biological process whose main goal is to eliminate selected cells for the benefit of the whole organism. Apoptosis can, for example, occur when a cell is damaged beyond repair, infected with a virus, or undergoing stress conditions such as starvation. The 'decision' for apoptosis can either come from the cell itself, or be induced from its surrounding environment (see [13] for a general introduction on apoptosis).
In the special case of lymphocytes, apoptosis plays an important role in optimising the functions of the immune system by compensating lymphocytes proliferation through the elimination of cells that have become ill or ineffective.
When apoptosis is not influenced by the presence of other cells, its effect can be considered as constant during the HIV infection, that is, the death rates of the cells related to apoptosis does not change with the evolution of the disease. In such a context, apoptosis is generally included in the natural death rate of each cell [represented by the terms (1) - (6)]. However, this cannot be the case for environment-dependent apoptosis. Indeed, as reported in [1, 4] , lymph nodes of HIV-infected individuals contain a high percentage (with respect to uninfected individuals) of uninfected CD4 þ and CD8 þ cells which are in an apoptotic state -that is which are ready to enter into an apoptotic process. Furthermore, these studies also showed that the apoptosis rates of these apoptotic cells were dependent on the stage of evolution of the HIV infection, and more specifically on the number of infected cells. As a general conclusion of these observations, the per-day proportion of uninfected but apoptotic CD4 þ and CD8 þ T-cells must be dependent on the number of infected cells and thus cannot be represented by constant factors (
as is the case for spontaneous apoptosis.
From a biological point of view, uninfected CD4
þ and CD8
þ T-cells have been shown to be prematurely marked for apoptosis because of the presence of biochemical messengers, for example, the glycoprotein gp120, one of the most well-established apoptosis-inducing factor [2, 3] . As summarised in [14, 15] , there are several main potential sources for apoptosis-inducing factors: infected cells or free virus particles expressing gp120 on their surface, soluble gp120 alone and Tat viral proteins. Other viral proteins, such as the accessory protein Nef [16] and possibly the immediate-early protein Vpr [17] may also induce apoptosis. Furthermore, some references [2] suggest the Figure 1 Time evolution of the state variables of the model (1) - (6) starting from the primo-infection initial condition
, 3198, 0, 0, 1, 10) existence of a two-step mechanism in which, first, T-cells are primed for a premature death by interaction with gp120, and secondly, the actual death signal is delivered by membrane-bound TNF-alpha on the surface of macrophages.
For the sake of obtaining a model which is able to qualitatively capture the activation-induced apoptosis phenomenon without becoming too complex for its analysis, we assume that all the potential apoptosis-inducing factors are directly correlated with the concentration of HIV-infected CD4
þ T-cells (T Ã 1 ) and that the activationinduced apoptosis signalling does not involve macrophages. Finally, we assume that the per-day apoptosis proportions depend linearly on the concentration of infected CD4 þ T-cells. It would also, for example, make sense to consider that the infected CD4 þ T-cells, macrophages and free HIV are correlated with the apoptosis-inducing factors. However, some side simulations and analysis not reported in this paper, have shown that replacing the term a
and a þ b ¼ 1 yields results which are qualitatively quite similar. This can be explained by the fact that the time evolutions of infected CD4
þ T-cells, macrophages and virions predicted by our model are highly correlated. The main reason for having adopted the simpler term a T 1 T Ã 1 was to obtain a model which could capture the fundamental dynamics associated with the activation-induced apoptosis phenomenon, while, at the same time, being simple enough to lend itself to a detailed analysis.
Consequently, we propose the following modification of the non-infected CD4 þ T-cells dynamics:
þ T-cells. According to our previously described assumptions, we assume that
where a T 1 is a non-negative parameter [expressed in ml/(cells Â day)] called the activation-induced apoptosis parameter of uninfected CD4 þ T-cells when in presence of infected CD4 þ T-cells (or apoptosis parameter for short). A similar modification is considered for the dynamics of CD8 þ cells. The corresponding modified model writes
where a T 1 and a E are expressed in ml/(cells Â day).
Analysis of the apoptosis-compliant model
In this section, we analyse the HIV infection dynamics model described by the system of ODEs (7) - (12). This analysis mainly focuses on the study of the influence of the apoptosis parameters a T 1 and a E on the modelled dynamics.
In order to study the influence of some parameters on the dynamics of a nonlinear system modelled by ODEs, one generally relies on a combination of two complementary approaches. The first one is a simulation-based approach which consists in numerically integrating the set of ODEs for different values of the system parameters (and often also for different initial conditions). The second one is more analytical and relies on a bifurcation analysis of the system with respect to the parameters of interest. This second approach aims at establishing the influence of the parameters of interest on the number, the stability and the position of the attractors of the system. More specifically, the simulation part allows us to identify typical asymptotic behaviours exhibited by the proposed model and to determine the time needed to reach a specific neighbourhood of these asymptotic behaviours. On the other hand, the bifurcation analysis provides a better insight into the dynamic mechanisms that correlate the apoptosis parameters a T 1 and a E with these asymptotic behaviours.
For the sake of simplicity, the analysis will start by considering that a E is equal to zero which is equivalent to neglecting activation-induced apoptosis in the dynamics of CD8 þ T-cells. Afterwards, we study the case where both a T 1 and a E are different from zero. To lighten the presentation of the results, we will mainly consider in our study a single initial state corresponding to the primo- 10 6 , 3198, 0, 0, 1, 10) and limit the range of values for a T 1 and a E to [0, 1] . Although this may seem to be restrictive, we found that the qualitative nature of our results were very robust with respect to 'biologically plausible' initial conditions. Furthermore, we believe that for values of a T 1 and a E greater than 1, the modelled activation-induced apoptosis rates become so important that they cannot remain in adequacy with reality. Indeed, such high values of the apoptosis parameters would yield an almost complete depletion of the T-cells within less than a few minutes. However, the position of this equilibrium was found to be highly dependent on the value of the apoptosis parameter a T
À5 , there is a sudden 'jump' towards a new position for which the corresponding asymptotic values of the state variables can be associated to a healthier situation, that is, the viral load and infected cells concentrations are drastically decreased, whereas the noninfected and HIV-specific cytotoxic T-cells concentrations are significantly increased. However, beyond the threshold value a T 1 ¼ 3:874 Â 10 À5 , this previously described healthier situation steadily degrades with increasing values of a T 1 . For values of a T 1 greater than say 10 23 , convergence to a point which is 'less healthy' than the 'non-healthy' equilibrium point described in Section 2.1 occurs.
In Fig. 2 we represent three typical time evolutions for the state variables of the model (7) - (12) when starting from the primo-infection point. These three time evolutions correspond to the following apoptosis parameter values a T 1 ¼ 10 À5 , a T 1 ¼ 10 À4 and a T 1 ¼ 10 À2 , respectively.
Up to this point, we have mainly focused on the study of the properties of the system (7)-(12) in asymptotic conditions. However, as illustrated in Fig. 3 , the time needed to reach a close neighbourhood of the asymptotic equilibrium values may be large. Some side simulations have shown that a significant increase in the settling-time values around the bifurcation threshold always occurs independently of the chosen initial condition. Therefore, the results presented in Fig. 3 for the primo-infection initial condition can be considered as representative for any initial condition. In particular, the time needed for the state-space trajectories to reach a neighbourhood of the equilibrium point to which they asymptotically converge is significantly increasing around the threshold value a T 1 ¼ 3:874 Â 10 À5 . This latter observation together with the fact that during the transient period the state variables deviation with respect to their asymptotic value may be significant (Fig. 2) show that the transient dynamics and settling time must also be taken into consideration when studying the effects of activation-induced apoptosis.
In order to obtain a better insight into the influence of the apoptosis parameter a T 1 on the dynamics of the proposed model, and especially to understand why there exists a range of values for a T 1 for which the patient state converges to an equilibrium point which is significantly healthier than the non-healthy equilibrium point described in Section 2, we perform, in Section 3.2, a detailed bifurcation analysis. 
Bifurcation analysis for a T 1 [ [0, 1] and a E ¼ 0
We performed a bifurcation analysis of the equilibrium points of the model (7) - (12) ], three equilibrium points coexist, two of them are locally stable (eq. point 1 and eq. point 2), whereas the remaining one is unstable. The asymptotic behaviour of the system depends on the chosen initial condition for the model. Performing simulations for a large number of 'biologically plausible' initial conditions, we have always observed convergence to one of the two locally stable equilibrium points. Furthermore, considering a T 1 [ [0, 3.874 Â 10 25 ] and starting from the primo-infection initial condition or a perturbed version of this initial condition convergence to the non-healthy stable equilibrium point (eq. point 2) has always been observed. During the simulations, we have considered perturbations for which the initial concentrations are defined as (k 1 10 6 , 3198, 0, 0, 1, 10). This latter observation confirms that the basin of attraction of the healthy equilibrium point (eq. point 1) is much smaller when compared with the one of the non-healthy equilibrium point (eq. point 2). At a T 1 ¼ 3:874 Â 10 À5 , the non-healthy equilibrium point (eq. point 2) coalesces with the unstable one through a saddlenode (also called limit point) bifurcation. We denote this point by LP 1 where LP stands for limit point. For values of a T 1 in the range [3.874 Â 10
25
, 1], a single locally stable equilibrium point exists (eq. point 1). Furthermore, as a T 1 increases towards 1, the position of this locally stable equilibrium (eq. point 1) evolves in such a way that T 1 eq , T 2 eq and E eq decrease, whereas T
and V eq increase, explaining the previously simulation-observed degradation in the patient state.
Remark: If one performs a bifurcation analysis for negative values of a T 1 , a second saddle-node bifurcation point appears, where eq. point 1 coalesces with the unstable equilibrium point. We denote this point by LP 2 . This point LP 2 has not been represented in Fig. 4 since negative values of a T 1 make no biological sense in our model. Nevertheless, noting the existence of this second saddle-node bifurcation point is important in order to understand the twoparameter bifurcation analysis presented in Section 3.3.
Analysis for a T 1 [ [0, 1] and a E [ [0, 1]
In this section, we additionally include the effect of activationinduced apoptosis on the CD8 þ T-lymphocytes and thus Figure 4 Bifurcation diagram of the equilibrium concentrations of non-infected CD4 þ T-cells (T 1 eq ) when the bifurcation parameter a T 1 varies from 0 to 10 24 .
A saddle-node bifurcation point (LP 1 ) exists at a T 1 ¼ 3.874 Â 10 25 . Only the infected equilibrium points (equilibrium points 2, 3 and 4) are represented and a E is chosen equal to 0. The equilibrium points at a T 1 ¼ 0 correspond to the three infected equilibrium points of the model (1)-(6) described in Section 2.1 consider the model (7) - (12) where both a T 1 and a E may take non-zero values. We first describe the results of a bifurcation analysis encompassing both the parameters a T 1 and a E . Afterwards, we discuss the additional information that simulations can bring with respect to this analysis. This twoparameter bifurcation analysis is based on a numerical continuation of the saddle-node bifurcation point LP 1 occurring at a T 1 , a E ¼ 3:874 Â 10 À5 , 0 (see [19, 20] for details about the continuation algorithm used). The corresponding two-parameter continuation diagram is given in Fig. 5 . In this latter figure, we can see that a CUSP bifurcation point exists at a T 1 , a E ¼ 4:838 Â 10 À4 , 1:956 Â 10 À4 À Á , (At the CUSP bifurcation point, two branches of saddle-node bifurcation curves meet tangentially. For nearby parameter values, the system can have three equilibria which collide and disappear pairwise via the saddle-node bifurcations.) At this point, two branches, LP 1 and LP 2 , of saddle-node bifurcation curves meet tangentially. These two branches divide the parameter plane into two regions. Inside the wedge between LP 1 and LP 2 , there are three equilibria, two stable (eq. points 1 and 2) and one unstable. Outside the wedge, there is a single equilibrium, which is stable. This equilibrium point may be either eq. point 1 or eq. point 2 depending if we are below LP 1 or above LP 2 . If we approach the CUSP point from inside the LP 1 -LP 2 wedge, all three equilibria merge together so that only a single stable equilibrium point remains beyond the CUSP bifurcation point.
To obtain a clear understanding of the influence of the two activation-induced apoptosis parameters a T 1 and a E on the set of reached equilibrium points when starting from the primoinfection initial condition we consider the 3D plot given in Fig. 6 . ], by increasing the value of a T 1 just above the corresponding threshold value defined by the LP 1 curve, there is a sudden change in the value of T 1 associated with the convergence point. This is due to the fact that below the LP 1 curve given in Fig. 5 , the system converges to an equilibrium point parented with the healthy equilibrium point (eq. point 1), as defined in Section 3.1, while above this curve it converges to a point parented with the non-healthy equilibrium (eq. point 2). Increasing the value of a T 1 further beyond this LP 1 -defined threshold value, the 'healthiness' (measured in proportion with the corresponding value of T 1 eq ) of the convergence point decreases with increasing values of a T 1 . It is also important to note that for any value of a T 1 , the healthiness of the convergence point always decreases with a E . These two parameters do not have the same effect on the HIV infection as can be seen from the asymmetry of the graphs given in Figs. 5 and 6. Actually, this can be explained by the fact that the death of CD4 þ T-cells by the activationinduced apoptosis can mitigate the HIV infection by limiting the number of cells in which the HIV can copy itself, whereas this is not the case for CD8 þ T-cells since they are not 
Figure 6 Concentrations of non-infected CD4
þ T-cells (T 1 ) corresponding to the equilibrium point to which the patient's state converges when starting from the primoinfection initial condition.
The saddle-node bifurcation curve LP 2 is not visible since starting from the primo-infection initial condition all trajectories corresponding to (a T 1 , a E )-values inside the LP 1 -LP 2 wedge converge to the 'non-healthy' stable equilibrium point (eq. point 2)
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Discussion
On the basis of the HIV infection dynamics model proposed by Adams in [7] , we have proposed an extended model which aims at incorporating the apoptosis-inducing effects that the HIV infection has on non-infected CD4 þ and CD8
þ T-cells.
The part of this model specific to these activation-induced apoptosis phenomena depends upon two apoptosis parameters which determine its magnitude (a T 1 and a E ). Using a combination of numerical simulations and bifurcation analysis, we found that for some ranges of values of these parameters, these activation-induced apoptosis phenomena could have some beneficial effects on the control of the HIV infection. Indeed, in those ranges, the effect of activationinduced apoptosis modifies the time evolution of the CD4 þ T-cells concentrations in a way which is particularly beneficial for preserving the immune system integrity. On the other hand, when the magnitude of the apoptosis parameters becomes too large, this potential beneficial effect disappears and the activation-induced apoptosis mechanisms were then found to aggravate the HIV infection. Furthermore, since the HIV infection worsens when these activation-induced apoptosis rates become too large, one could also relate the progression of the HIV infection to AIDS to a change of magnitude in these rates. These findings need to be taken with caution since they are dependent on several modelling assumptions (per-day apoptosis proportions are linearly proportional to the concentration of infected CD4 þ cells and the propensity non-infected CD4 þ and CD8 þ cells have to undergo apoptosis is proportional to their concentration) that would certainly require careful experimental validation.
We emphasise that these results could also potentially help in designing new anti-HIV therapies based on a drugmediated regulation of the activation-induced apoptosis factors (such as gp120) in HIV-infected patients. These therapies could be based on the injection of some specific interleukins to HIV positive patients, such as for example IL-2, IL-7 and IL-15. Interleukins are a group of cytokines (secreted signalling molecules) that are used for ensuring communication between cells. The functions of the immune system strongly depend on interleukins as they provide means of communication (and thus of collaboration) between the different groups of immune system cells. Indeed, the anti-apoptotic effect of these interleukins has been reported in the literature [6, 14, 21] . For example, Ahr et al. [14] suggest that IL-15 could be used as an immunorestorative agent in HIV treatment because of its anti-apoptotic properties, and its role in enhancing survival and functions of CD8 þ T-cells. Also, the in vitro results presented in [6] highlight the beneficial anti-apoptotic effects of IL-2 and IL-7 on CD4 þ and CD8
þ T-cells of HIV-infected patients. However, the role of interleukins on the immune system of HIV-infected patients/macaques is still a controversial issue since other studies [22] have shown that they could have a detrimental effect. Nevertheless, these contradictory results concerning the effects of interleukins on the HIV infection could potentially be explained by the analysis of our extended model, which shows that a decrease in apoptosis rates does not necessarily lead to a better immune system response.
Finally, we acknowledge that the model proposed in this paper possesses some limitations. In particular, similar to the model initially proposed by Adams et al., our model is not able to predict the in vivo observed long-term collapse of the immune system, which may be due to several factors such as virus mutations, or fatigue of the immune system resulting in progressive thymus degradation. In ongoing research, we investigate some modifications of the proposed model to overcome these limitations. Also, our model does not encompass the effects of highly active anti-retroviral drugs and of activation-induced apoptosis on the HIV dynamics. More research would certainly be useful to explore ways to design models that overcome these two limitations.
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